Delivery Order SPE2DB22D9353-SPE2DB24FX2CE

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $5.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of PEDVAXHIB vaccine vials, with a potential value of $1,167.60 and a completion date of February 16, 2024. The contract is not designated as a set-aside. It is issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDV)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of PEDVAXHIB Vaccine Vial 0.5ML, with a ceiling value of $3,585.06 and a period of performance through March 24, 2025. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,784.00 firm fixed-price contract is to provide the PEDVAXHIB vaccine in 0.5 ml vials to fulfill the recurring pharmaceutical supply needs of military health facilities. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division of the Department of Defense. The $1,282.40 order is for the supply of PEDVAXHIB 0.5ML 10S, a pharmaceutical product, with a period of performance through May 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of PEDVAXHIB vaccine vials, 0.5 milliliters each, with a ceiling value of $1,792.53 and a performance period ending on April 24, 2025. The contract is a firm fixed-price delivery order and was not set aside for any specific program. DMS Pharmaceutical Group holds a larger...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,556.80 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML. This delivery order is part of a larger indefinite delivery contract, SPE2DB, valued up to $4,999,999 through 2025, that allows DLA to issue delivery orders for a broad range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the procurement of PEDVAXHIB VACCINE VIAL 0.5ML, valued at $1,593.36, with a performance period through March 26, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $2,191.94 and covers the delivery of PEDVAXHIB Vaccine vials to support military healthcare needs. The contract does not have a set-aside designation. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PEDVAXHIB vaccine vials. The contract has a ceiling value of $7,583.60 and a period of performance through June 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical division, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PEDVAXHIB 0.5ML 10S, a vaccine product, at a firm fixed price of $10,301.02. The contract has an ultimate completion date of July 29, 2024 and was awarded on July 26, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which...
  • SPE2DB22D9353
    Indefinite Delivery Contract
  • SPE2DB22D9353-SPE2DB24FX2CE
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of PEDVAXHIB vaccine vials in 0.5 ml doses, with a ceiling value of $5,838.00 and an ultimate completion date of August 15, 2024.

The contract is not set-aside and is part of a larger indefinite delivery contract (IDC) vehicle held by DMS Pharmaceutical Group Inc. with the DLA, valued at up to $499,999,999 and running through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. Through this vehicle, DMS Pharmaceutical Group provides both routine and critical medications to the Department of Defense (DoD) healthcare system.

Generated 11/13/24, 9:18 AM